Finance

Lists
GUD:TSE
Knight Therapeutics Inc
CA$ १०.६८
-१.३९%
(-०.१५) 1D
अक्टोबर १३, १६:००:०१ GMT-४  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for GUD...
Open
CA$ १०.८४
High
CA$ १०.८४
Low
CA$ १०.६५
Mkt. cap
१.०५ अरब
Avg. vol.
८१.७९ हजार
Volume
९३.७४ हजार
P/E ratio
७१.२१
52-wk high
CA$ ११.००
52-wk low
CA$ ५.६६
EPS
CA$ ०.१५
Beta
-०.०७
Shares outstanding
९.८२ करोड
No. of employees
८३०
Open
CA$ १०.८४
High
CA$ १०.८४
Low
CA$ १०.६५
Mkt. cap
१.०५ अरब
Avg. vol.
८१.७९ हजार
Volume
९३.७४ हजार
P/E ratio
७१.२१
52-wk high
CA$ ११.००
52-wk low
CA$ ५.६६
EPS
CA$ ०.१५
Beta
-०.०७
Shares outstanding
९.८२ करोड
No. of employees
८३०
News stories
From web sources and news partners
GlobeNewswire
GlobeNewswire
·
२८ मिनेट पहिले
FBS Global Regains Compliance with Nasdaq Minimum Bid Price Requirement
Investor's Business Daily
Investor's Business Daily
·
२४ मिनेट पहिले
Dow Jones Futures: Stock Market Holds Up As Meta, AMD Lead Buys; ASML, CPI Inflation Due
10TV
10TV
·
३८ मिनेट पहिले
How major US stock indexes fared Tuesday 10/13/2026
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees८३०
Founded२०१४
Headquartersमोन्ट्रियल, क्युबेक, क्यानाडा
Sector-
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
-CA$ ०.०३ /
०.००%miss
Revenue / Est. (CAD)
१४.४२ करोड / १२.८९ करोड
+११.८८%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१२.१५ करोड
१३.३१ करोड
१४.८४ करोड
१४.४२ करोड
Cost of goods sold
६.५७ करोड
६.८४ करोड
७.९३ करोड
७.४६ करोड
Cost of revenue
६.५७ करोड
६.८४ करोड
७.९३ करोड
७.४६ करोड
Research and development expenses
८६.९४ लाख
९२.२३ लाख
९४.१० लाख
१.०६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.१० करोड
३.५५ करोड
३.४४ करोड
३.६६ करोड
Operating expense
५.५२ करोड
५.८५ करोड
५.८५ करोड
६.०७ करोड
Total operating expenses
१२.०९ करोड
१२.६९ करोड
१३.७९ करोड
१३.५३ करोड
Operating income
६.४६ लाख
६२.१० लाख
१.०६ करोड
८९.६० लाख
Other non operating income
-२.७१ लाख
३.२९ लाख
४१.७४ लाख
-४.८७ लाख
EBT including unusual items
-१९.१७ लाख
१.१२ करोड
१.४२ करोड
-२१.०३ लाख
EBT excluding unusual items
२२.३८ लाख
१५.७४ लाख
१.५५ करोड
७२.०७ लाख
Income tax expense
१८.७४ लाख
२३.७० लाख
१०.१३ लाख
१२.५८ लाख
Effective tax rate
-९७.७६%
२१.१२%
७.१४%
-५९.८२%
Other operating expenses
-
-
-
-
Net income
-३७.९१ लाख
८८.५४ लाख
१.३२ करोड
-३३.६१ लाख
Net profit margin
-३.१२%
६.६५%
८.८७%
-२.३३%
Earnings per share
-०.०२
०.१०
०.१४
-०.०३
Interest and investment income
११.०७ लाख
१२.१९ लाख
९.५२ लाख
९.०१ लाख
Interest expense
-२३.६८ लाख
-३९.२४ लाख
-२६.४१ लाख
-२१.२५ लाख
Net interest expenses
-१२.६१ लाख
-२७.०५ लाख
-१६.८९ लाख
-१२.२४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
१.८४ करोड
१.६५ करोड
२.६८ करोड
२.४० करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू